The Food and Drug Administration's role in promoting consistent labels for generic drugs

JAMA Intern Med. 2014 Aug;174(8):1213-4. doi: 10.1001/jamainternmed.2014.2705.

Authors

Jon D Duke¹, Aaron S Kesselheim²

Affiliations

¹ Regenstrief Institute, Indianapolis, Indiana2Department of Medicine, Indiana University School of Medicine, Indianapolis.
² Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

PMID: 24957047
DOI: 10.1001/jamainternmed.2014.2705

No abstract available

MeSH terms

Drug Labeling / legislation & jurisprudence
Drug Labeling / standards*
Drug-Related Side Effects and Adverse Reactions*
Drugs, Generic*
Humans
United States
United States Food and Drug Administration*

Substances

Drugs, Generic